Wegovy weight loss pill arrives on pharmacy shelves 

Novo Nordisk's oral semaglutide is one of two oral GLP-1s recently approved by the TGA.

Novo Nordisk’s Wegovy pill has become the first oral GLP-1 medication for weight management to arrive on Australian pharmacy shelves. 

The oral version of semaglutide became available to purchase today with a private prescription.

It comes just days after competitor Eli Lilly announced that its weight loss pill, orforglipron (Foundayo), had been approved by the TGA and stock would reach pharmacies imminently.

Novo Nordisk’s Wegovy pill was greenlit by the regulator earlier this month.